The Burden of Post-COVID-19 Conditions is Analyzed in IQVIA Report
Many COVID-19 survivors develop long-term conditions after they have recovered from the virus. Considering the have been 250 million reported [...]
Interview with Scott Gottlieb on COVID, the CDC, and More
Gottlieb Scott Gottlieb, former CDC director, sat down for an interview with Stat News to discuss his new [...]
Cerner Database Reveals COVID Death Rate Lower When Taking SSRIs
COVID Death Rate Lower When Taking SSRIs Electronic health records (EHR) from the Cerner Real World COVID-19 de-identified database indicate [...]
CADTH Annual Report 2020–2021
The theme of the Canadian Agency for Drugs and Technologies in Health’s (CADTH) annual report for 2020-2021 was “unprecedented.” The [...]
2022 Predictions: Ezekiel Emanuel Fireside Chat
Image by: Samuel Masinter (CC by 3.0) On Wednesday, December 1st, 2021, esteemed oncologist and policymaker Dr. Ezekiel [...]
Papa Raises $150 Million in Series D Funding, Seeks to Improve Health Equity
The startup Papa has raised $150 million in series D funding. The company aims to address loneliness by connecting seniors [...]
TransUnion Reports Widespread Delay of Healthcare as Coverage Gaps Increase and COVID-19 Uncertainty Continues
According to TransUnion, approximately 35% of patients with medical debt have put off healthcare in the past year. Key factors [...]
Upcoming December Webinar on RWE in Pharma Featuring Leaders at IQVIA, Roche, and Janssen
The Evidence Base will host a webinar on real world evidence (RWE) in pharma at 7:00 AM on December 8th, [...]
Value & Outcomes Spotlight Announces 2022 Themes
The 2022 themes of Value & Outcomes Spotlight are now available. They include submissions on global price transparency, patient advocacy, [...]
Understanding the Power of Platform Trials
A recent Cytel blog post details the benefits of one category of the Master Protocol termed the platform trial, typically [...]
Parexel VPs Discuss COVID-19, RWE, and New Challenges
Parexel’s Leanne Larson and Matthew Gordon shared their thoughts on the growing importance of real world evidence (RWE) in clinical [...]
PRMA Consulting Leader Discusses Strategies to Address Healthcare Inequities
PRMA Consulting’s Alisha Robert discusses how organizations can address healthcare inequities. Key strategies include using social determinants of health combined [...]
Eli Lilly CEO Shares Thoughts on How Medicare Pricing Measures Could Impact Innovation
Eli Lilly CEO David Ricks shared his thoughts on how policies intended to lower drug prices would negatively impact pharmaceutical [...]
RWD Study Finds Association Between High BMI and COVID-19 Risk
Researchers used Swedish real world data (RWD) to understand risk factors linked to poor COVID-19 outcomes. The investigators identified a [...]
HealthVerity’s RWD Platform Informs Government Response to COVID-19
HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 [...]
ISPOR Director Discusses Global Commitment to Improving HEOR
Director of Global Networks at the International Society for Pharmacoeconomics and Outcomes (ISPOR) Robert Selby discussed ISPOR’s worldwide initiative intended to [...]
FDA Directors Discuss EUAs, Transparency, and COVID-19
In a recent meeting, Food and Drug Administration directors discussed how emergency use authorizations (EUAs) affected the response to the [...]
Employer Healthcare Costs Will Increase 5% in 2022 as the COVID-19 Pandemic Continues
A recent report released by Willis Towers Watson notes an expected 5% increase in healthcare costs in 2022. Premiums and [...]
ICER VP of Research Recognized as Emerging Health Leader, Seeks to Improve Health Equity
Foluso Agboola, a Nigerian researcher who pursued her training at Harvard before joining the Institute for Clinical and Economic Review [...]
PRMA Consulting Senior Advisor Discusses the Four Pillars of Market Access and New Pharma Trends
Senior Advisor, Asia-Pacific at PRMA Consulting Jeff Weisel shared an update to his previous article detailing the four strategic pillars [...]
The future of market access: a new model for the ‘next normal’
The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access.
Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance
According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) [...]
Register Now for MAPS 2022 in New Orleans
The Medical Affairs Professional Society (MAPS) will host its next Global Annual Meeting in March 2022. The meeting will draw [...]
Report on North America HEOR Market Forecast to 2027 Now Available
A new report discusses emerging and continuing trends in North America in health economics and outcomes research (HEOR). The report [...]
PhRMA Seeks to Address Health Disparities and COVID-19 Impact, Awards $150,000 in Community-Level Grants
PhRMA has announced four health disparity initiatives that will receive a quarter of $150,000. The programs tackle COVID-19 vaccine hesitancy, [...]